ERYTHROMYCIN OPHTHALMIC OINTMENT USP
STERI-MED PHARMA INC.
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of ERYTHROMYCIN OPHTHALMIC OINTMENT USP in Canada?
Yes. ERYTHROMYCIN OPHTHALMIC OINTMENT USP 5MG has an active shortage reported to Health Canada (last updated October 15, 2026).
Why is ERYTHROMYCIN OPHTHALMIC OINTMENT USP not available?
The reason the manufacturer reported: Demand increase for the drug.
When will ERYTHROMYCIN OPHTHALMIC OINTMENT USP be available again?
The manufacturer's estimated resolution date is December 14, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
ERYTHROMYCIN
PHARMA STULLN INC.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
ERYTHROMYCIN OPHTHALMIC OINTMENT USP
ERYTHROMYCIN OPHTHALMIC OINTMENT USP: The sterility of the product could be compromised.
Moderate health risk
Possible match — not confirmed
ERYTHROMYCIN OPHTHALMIC OINTMENT USP
ERYTHROMYCIN OPHTHALMIC OINTMENT USP: Product sterility may be compromised
Moderate health risk
Possible match — not confirmed
ERYTHROMYCIN OPHTHALMIC OINTMENT USP
ERYTHROMYCIN OPHTHALMIC OINTMENT USP: Sterility Concerns
Moderate health risk
Possible match — not confirmed
DIN
02326663
Strength
5MG
Dosage Form
OINTMENT
Route
OPHTHALMIC
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from STERI-MED PHARMA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.